Search clinical trials for: Androgen Receptor Degrader,
Total 19497 results
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
AstraZenecaParexelCompletedHealthy SubjectsUnited Kingdom
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Transformation | DLBCL UnclassifiableChina
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Portugal, Spain, Taiwan, Costa Rica, New Zealand, Poland, Chile, Colombia, Guatemala, Israel, Hungary, India, Thailand
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Accutar Biotechnology IncRecruiting
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Poland
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Nurix Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Primary Central Nervous System Lymphoma (PCNSL) | Marginal Zone Lymphoma (MZL) | Waldenstrom Macroglobulinemia (WM) | Diffuse Large B Cell Lymphoma (DLBCL)United States, United Kingdom, Netherlands
-
Roswell Park Cancer InstituteNot yet recruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma and other conditionsUnited States
-
Nurix Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Primary Central Nervous System Lymphoma (PCNSL) | Marginal Zone Lymphoma (MZL) | Waldenstrom Macroglobulinemia (WM)United States
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingAdvanced Breast CancerChina, Japan, United States, Taiwan, Canada, Korea, Republic of, Spain, Bulgaria, Turkey, Finland, Italy, Czechia, India, Slovakia, South Africa, Germany, Australia, Brazil, Greece, Puerto Rico, Belgium, Argentina, Switzerland, Poland, ... and more
-
Accutar Biotechnology IncRecruitingRelapsed/Refractory B-cell MalignanciesUnited States
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Arvinas Inc.RecruitingRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)United States, Spain
-
University of MiamiNot yet recruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; Kom Op Tegen Kanker; Teva PharmaRecruitingTriple Negative Breast NeoplasmsBelgium
-
Peking University First HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.; Beijing Biote Pharmaceutical Co.,LtdRecruitingSalivary Gland Neoplasm DuctChina
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Instituto BernabeuNot yet recruiting
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH)Not yet recruitingProstate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of ProstateUnited States
-
Duke UniversityMemorial Sloan Kettering Cancer Center; University of Wisconsin, MadisonNot yet recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic
-
Peking Union Medical College HospitalNot yet recruitingSleep Disorder | Menopause
-
Chang Gung Memorial HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingDuctal Carcinoma in SituUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | MutationChina
-
Novartis PharmaceuticalsRecruitingProstatic NeoplasmKorea, Republic of, Singapore, United States, Canada, Poland, Spain, Czechia
-
Brown UniversityCures Within Reach; Lifespan; Legorreta Cancer Center at Brown UniversityRecruitingUrothelial Carcinoma Bladder | Androgen Receptor PositiveUnited States
-
Janssen Research & Development, LLCRecruitingMetastatic Castration-resistant Prostate NeoplasmsUnited States, Australia
-
University of ChicagoRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of Colorado, DenverRecruitingHypertension | Prostate Cancer | Autonomic Dysfunction | Androgen Deprivation Therapy | Renal DiseaseUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
University of Wisconsin, MadisonRecruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
McGill University Health Centre/Research Institute...Not yet recruitingEndometriosis | FibroidsCanada
-
Banaras Hindu UniversityRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate CancerBelgium
-
Far Eastern Memorial HospitalRecruiting
-
Instituto de Investigación en Oncología Radioterápica...Instituto de Investigación en Oncología Radioterápica FEOR (IRAD-FEOR)RecruitingProstate Cancer | Stereotactic Body Radiation TherapySpain
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Janssen-Cilag Ltd.Recruiting
-
University of NicosiaNot yet recruitingEndometrial Disorder | Androgen Receptor Abnormal
-
Qingdao Central HospitalRecruiting